Skip to main content
Skip to footer
Gaylord Specialty Healthcare First in Nation to Adopt Ground-Breaking Pharyngeal Electrical Stimulation Technology to Treat Patients with Dysphagia Read More Phagenesis Launches Phagenyx Neurostimulation System in the U.S. Read More Phagenesis Selected for MedTech Innovator’s 2022 Cohort Read More Rapid Swallow Improvement Following Pharyngeal Electrical Stimulation In a COVID-19 Patient With Long-Term Severe Neurogenic Dysphagia: A Case Report Read More Pharyngeal electrical stimulation helps critically ill COVID-19 patients with dysphagia recover safely: a case report using the Phagenyx® PES System Read More Largest real-world study of Phagenyx® demonstrates significant benefits of treatment in patients with unsafe swallowing (neurogenic dysphagia) resulting from multiple causes Read More
